Headquarters
USA

Owkin

The company deploys AI and federated learning for medical research and aims to empower researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhancethe drug development process, and identify the best drug for the right patient to improve treatment outcomes.

It was co-founded in 2016 by Thomas Clozel, a hematologist oncologist and researcher, and Gilles Wainrib, a computer science teacher-researcher in New York, New York.

Visite el sitio web de Owkin

Suscribirse a las actualizaciones

Una actualización semanal de lo que hay en la Agenda Global

© 2021 World Economic Forum

Política de privacidad y normas de uso